FDA Widens Warning for Contaminated Eye Products

WEDNESDAY, Feb. 22, 2023 (HealthDay News) -- On Wednesday, the U.S. Food and Drug Administration warned consumers to stop buying or using the Delsam Pharma Artificial Eye Ointment. The over-the-counter product is made by the same company that makes eye drops that were recalled earlier this year amid an outbreak of a highly drug-resistant bacteria that has hospitalized and blinded patients.
Those products, which include EzriCare and Delsam Pharma artificial tears, are manufactured and exported by the Indian company Global Pharma Healthcare Private Limited. The FDA faulted the company for multiple violations, and has banned imports of the company's items into the United States. It is not clear what prompted the most recent warning, CBS News said.
At least 16 patients had been hospitalized earlier for an outbreak of the "rare, extensively drug-resistant" Pseudomonas aeruginosa bacteria, a strain that had not been seen in the United States before. The U.S. Centers for Disease Control and Prevention has issued a nationwide health alert about the bacteria.
The outbreak involved patients in 12 states. Five were permanently blinded. One had to have an eyeball surgically removed, CBS News reported. A patient in Washington state died when the infection spread to the bloodstream.
Federal investigators found opened EzriCare eye drops contaminated with the bacteria at the homes of multiple patients. However, three unopened bottles did not have signs of contamination. Investigators are testing more bottles.
Most patients bought the drops online, though one reported buying it in a Costco warehouse, CBS News reported. The Delsam Pharma Artificial Eye Ointment is still listed for sale on several websites, including Amazon.
Related Posts
El vapeo no es una gran ayuda para dejar de fumar, según un estudio
MARTES, 8 de febrero de 2022 (HealthDay News) -- Los cigarrillos electrónicos se...
Los deportes como el fútbol y el básquetbol son mejores que correr para los huesos de los jóvenes
VIERNES, 14 de octubre de 2022 (HealthDay News) -- Practicar deportes puede...
CT Scans Beat Gene Scores at Predicting Mid-Life Heart Risk
TUESDAY, May 23, 2023 (HealthDay News) -- When it comes to predicting heart...
USPSTF: Evidence Still Lacking for Routine Skin Cancer Screening
TUESDAY, Oct. 25, 2022 (HealthDay News) -- The U.S. Preventive Services Task...